Related Experiment Video

Updated: Jun 22, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Best Practice Guidelines for treatment of hypercholesterolaemia: a statement from the Caribbean Cardiac Society

E E Chung1,

  • 1Caribbean Cardiac Society, The University of the West Indies, Kingston 7, Jamaica, West Indies. echung@mail.infochan.com

The West Indian Medical Journal
|July 2, 2009
PubMed

Insights

The Caribbean faces rising chronic non-communicable diseases. This guideline provides best practices for managing high cholesterol (hypercholesterolaemia) to prevent heart disease.

Area of Science:

  • Cardiology
  • Public Health
  • Caribbean Health

Background:

  • The Caribbean is experiencing a shift towards chronic non-communicable diseases.
  • Hypertension, obesity, diabetes mellitus, and hyperlipidaemia are key risk factors for coronary atherosclerosis.
  • The Caribbean Cardiac Society identified a need for regional best practice guidelines.

Purpose of the Study:

  • To establish best practice guidelines for hypercholesterolaemia therapy in the Caribbean.
  • To address the increasing prevalence of cardiovascular risk factors in the region.

Main Methods:

  • A consensus conference was convened by the Caribbean Cardiac Society in 2005.
  • Discussions focused on hypercholesterolaemia, hypertension, diabetes mellitus, and obesity.
  • Recommendations were developed for the management of hypercholesterolaemia.

Main Results:

  • The consensus group developed recommendations for the therapy of hypercholesterolaemia.
  • These guidelines aim to foster best practices in the Caribbean region.

Conclusions:

  • Implementing these best practice guidelines is crucial for managing hypercholesterolaemia.
  • Addressing cardiovascular risk factors is essential for public health in the Caribbean.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...